Why Your ED Prescription May Be the Wrong Dose for Your Body — And What to Do About It

When a physician writes a prescription for an erectile dysfunction medication, the path of least resistance is well-worn: a standard starting dose, a brief follow-up, and an assumption that the medication will perform as expected. For a significant portion of men, it does not. The pill either underdelivers — producing little to no improvement — or it overshoots, generating headaches, flushing, or blood pressure fluctuations that discourage continued use.

The frustrating reality is that neither outcome necessarily reflects a failure of the drug class itself. It may reflect a failure of personalization.

The Standard-Dose Assumption and Why It Falls Short

FDA-approved phosphodiesterase type 5 (PDE5) inhibitors — including sildenafil, tadalafil, vardenafil, and avanafil — are each approved at specific dose ranges. Prescribers often default to midrange doses because they represent the broadest statistical efficacy across clinical trial populations. Clinical trials, however, are designed to demonstrate average outcomes across large, diverse groups. Your body is not an average.

Age, liver function, kidney health, body composition, concurrent medications, and cardiovascular status all influence how quickly a drug is absorbed, how efficiently it is metabolized, and how long it remains therapeutically active. A 42-year-old man with no chronic conditions and a healthy weight processes sildenafil very differently than a 67-year-old man managing type 2 diabetes and hypertension. Prescribing the same dose to both and expecting equivalent results reflects a fundamental misunderstanding of pharmacokinetics.

Research published in peer-reviewed urology and sexual medicine journals consistently demonstrates that dose optimization — adjusting upward or downward based on individual response and tolerability — significantly improves both efficacy rates and patient satisfaction. Yet dose titration remains underutilized in routine clinical practice.

How Metabolism Shapes Your Medication's Performance

The liver enzyme CYP3A4 plays a central role in breaking down all PDE5 inhibitors. Men who metabolize this enzyme rapidly may find that a standard dose clears their system before it has time to work effectively. Conversely, men who are slow metabolizers — or who take medications that inhibit CYP3A4, such as certain antifungals or HIV protease inhibitors — may experience amplified effects and a higher risk of side effects at doses that would be perfectly appropriate for someone else.

Age compounds this dynamic. Hepatic blood flow decreases with age, slowing the metabolism of many drugs. The FDA's prescribing information for sildenafil, for example, explicitly notes that plasma concentrations in men over 65 are approximately 40 percent higher than in younger men at equivalent doses. This pharmacokinetic reality is not always reflected in how prescriptions are written during a brief office visit.

Renal function matters as well. Men with reduced kidney clearance may accumulate higher drug concentrations than intended, increasing both the duration of effect and the likelihood of adverse reactions. A thorough medication review that accounts for kidney and liver health is a reasonable precondition to finalizing any ED treatment plan.

The Financial Toll of Mismatched Prescribing

Beyond the clinical consequences, there is a direct economic cost to imprecise prescribing. Men who receive an ineffective dose may cycle through multiple refills before concluding — incorrectly — that the medication does not work for them. Others may escalate to branded formulations or combination therapies when a simple dose adjustment of a generic medication would have resolved the problem at a fraction of the price.

Generic sildenafil and tadalafil are widely available in the United States at dramatically lower prices than their branded counterparts, but this cost advantage evaporates when a man is taking the wrong dose or the wrong formulation for his physiology. A 100 mg sildenafil tablet split into 50 mg doses may be clinically appropriate and cost-efficient for one man, while another may require a lower, 25 mg dose to avoid side effects — or a higher one to achieve adequate response. Without individualized assessment, neither scenario is systematically pursued.

Formulation Differences That Prescribers Often Overlook

Dose is only one dimension of personalization. Formulation choice also carries significant clinical weight.

Tadalafil, for instance, is available both as an on-demand dose (typically 10 or 20 mg taken before anticipated sexual activity) and as a lower daily dose (2.5 or 5 mg). Men who find the timing pressure of on-demand dosing stressful — or who have sex more than twice weekly — may find daily tadalafil not only more convenient but therapeutically superior for their lifestyle. Yet many men are never offered this option during their initial prescription conversation.

Avanafil, the newest FDA-approved PDE5 inhibitor, has a faster onset of action than sildenafil or tadalafil and a more selective pharmacological profile that some men tolerate better. It remains underutilized largely because it lacks generic availability and carries a higher price point — but for men who experience persistent side effects with other agents, it may represent a meaningful clinical upgrade worth discussing.

Building the Case for a Personalized Treatment Conversation

Advocating for individualized dosing does not require a confrontational dynamic with your physician. It requires preparation and specific questions.

Before your next appointment — or before initiating treatment for the first time — consider compiling the following:

• A complete medication list, including over-the-counter supplements, which can interact with PDE5 inhibitors in ways that alter their metabolism
• Recent lab work, particularly kidney function (creatinine, eGFR) and liver panels, which directly inform dosing decisions
• An honest account of lifestyle factors: alcohol consumption, smoking history, exercise habits, and sleep quality all influence vascular health and drug response
• A description of any previous ED medication experiences, including what worked, what did not, and what side effects occurred at what doses

With this information in hand, a clinically engaged conversation about dose optimization becomes far more productive. Specific questions worth raising include: Is this starting dose appropriate given my age and other health conditions? Are there formulation alternatives I should consider? How should I assess whether this dose is working, and when would it make sense to adjust it?

The Role of Telehealth in Enabling More Personalized Care

The expansion of telehealth platforms has created new opportunities for more thorough initial assessments than a five-minute in-office encounter typically allows. Many men find that asynchronous questionnaire-based consultations — where they can provide detailed health histories, list all current medications, and describe prior treatment experiences — result in more thoughtfully calibrated prescriptions than they received through traditional channels.

This does not mean that all telehealth providers offer superior personalization. Quality varies considerably. Men should look for platforms that conduct thorough intake processes, involve licensed physicians or nurse practitioners in prescribing decisions, and have clear protocols for dose adjustment follow-up rather than simply renewing the same prescription indefinitely.

Precision Is Not a Luxury — It Is the Standard of Good Care

The notion that ED medication prescribing is straightforward — that any licensed provider can write the same prescription for every man and expect comparable results — has persisted largely because men have not pushed back against it. The clinical evidence, however, supports a more individualized approach, and the financial logic reinforces it.

A treatment plan built around your specific physiology, health history, and lifestyle is not an unreasonable expectation. It is the foundation of effective care. Men who invest time in advocating for that level of precision are not being demanding — they are exercising the same informed judgment they would apply to any other significant medical decision.

At VitalEdge Health, our commitment is to provide the information men need to pursue treatment that actually works — not just treatment that is statistically average.